About Novanta Inc
Ticker
info
NOVT
Trading on
info
NASDAQ
ISIN
info
US67000B1044
Industry
info
Scientific & Technical Instruments
Sector
info
Technology
CEO
info
Matthijs Glastra
Headquarters
info
125 Middlesex Turnpike, Bedford, MA, United States, 01730
Employees
info
3,000
Website
info
novanta.com
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$4.22B
P/E ratio
info
80.42
EPS
info
$1.46
Dividend Yield
info
0.00%
Beta
info
1.59
Forward P/E ratio
info
0
EBIDTA
info
$180M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.22B
Average daily volume
info
0.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
80.42
Forward P/E
info
0
PEG ratio
info
2.11
Trailing P/E
info
80.42
Price to sales
info
4.4
Price to book
info
5.1
Earnings
EPS
info
$1.46
EPS estimate (current quarter)
info
$0.82
EPS estimate (next quarter)
info
$0.94
EBITDA
info
$180M
Revenues (TTM)
info
$960M
Revenues per share (TTM)
info
$26.68
Technicals
Beta
info
1.59
52-week High
info
$173.16
52-week Low
info
$98.27
50-day moving average
info
$110.43
200-day moving average
info
$121.01
Short ratio
info
3.16
Short %
info
10.22%
Management effectiveness
ROE (TTM)
info
6.84%
ROA (TTM)
info
5.18%
Profit margin
info
5.50%
Gross profit margin
info
$433M
Operating margin
info
11.51%
Growth
Quarterly earnings growth (YoY)
info
-44.10%
Quarterly revenue growth (YoY)
info
1.40%
Share stats
Outstanding Shares
info
35.8M
Float
info
35.5M
Insiders %
info
1.03%
Institutions %
info
103.09%
Analyst Insights & forecasts
info

75% Buy

25% Hold

0% Sell

Based on information from 4 analysts.

Average price target

info
$154.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.76
$0.71
6.55%
Q4 • 24Beat
$0.59
$0.67
-12.82%
Q1 • 25Missed
$0.76
$0.73
4.11%
Q2 • 25Beat
$0.87
$0.84
3.57%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$241M
$4.5M
1.87%
Q2 • 25
$248M
$10.7M
4.30%
Q3 • 25
2.82%
136.89%
130.40%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.51B
$710M
46.96%
Q2 • 25
$1.51B
$704M
46.77%
Q3 • 25
-0.35%
-0.75%
-0.40%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$15.1M
$-66.6M
$54.8M
$11.7M
Q2 • 25
$8.5M
$-5.4M
$-23.4M
$4.2M
Q3 • 25
-43.64%
-91.89%
-142.71%
-63.95%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Novanta Inc share?
Collapse

Novanta Inc shares are currently traded for undefined per share.

How many shares does Novanta Inc have?
Collapse

Novanta Inc currently has 35.8M shares.

Does Novanta Inc pay dividends?
Collapse

No, Novanta Inc doesn't pay dividends.

What is Novanta Inc 52 week high?
Collapse

Novanta Inc 52 week high is $173.16.

What is Novanta Inc 52 week low?
Collapse

Novanta Inc 52 week low is $98.27.

What is the 200-day moving average of Novanta Inc?
Collapse

Novanta Inc 200-day moving average is $121.01.

Who is Novanta Inc CEO?
Collapse

The CEO of Novanta Inc is Matthijs Glastra.

How many employees Novanta Inc has?
Collapse

Novanta Inc has 3,000 employees.

What is the market cap of Novanta Inc?
Collapse

The market cap of Novanta Inc is $4.22B.

What is the P/E of Novanta Inc?
Collapse

The current P/E of Novanta Inc is 80.42.

What is the EPS of Novanta Inc?
Collapse

The EPS of Novanta Inc is $1.46.

What is the PEG Ratio of Novanta Inc?
Collapse

The PEG Ratio of Novanta Inc is 2.11.

What do analysts say about Novanta Inc?
Collapse

According to the analysts Novanta Inc is considered a buy.